Skip to main content
. 2012 Aug 27;45(5):413–419. doi: 10.1111/j.1365-2184.2012.00837.x

Figure 3.

Figure 3

Inhibition of tumorosphere formation by EGFR inhibitors. (a) The cell viability was determined by MTT assay after 72 h incubation EGFR inhibitors, gefitinib; (b,c) Concentration‐dependent inhibition of tumorosphere formation by the EGFR inhibitors, gefitinib and PD153035; (d) HCT116 forms spheres in the presence or absence of gefitinib (×40).